Deal, C. L., Mitlak, B. H., Wang, Y., Fitzpatrick, L. A., & Miller, P. D. (2019). Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend. Bone Rep.

Deal, Chad L., Bruce H. Mitlak, Yamei Wang, Lorraine A. Fitzpatrick, and Paul D. Miller. "Response Rates for Hip, Femoral Neck, and Lumbar Spine Bone Mineral Density in Patients Treated With Abaloparatide Followed By Alendronate: Results From Phase 3 ACTIVExtend." Bone Rep 2019.

Deal, Chad L., et al. "Response Rates for Hip, Femoral Neck, and Lumbar Spine Bone Mineral Density in Patients Treated With Abaloparatide Followed By Alendronate: Results From Phase 3 ACTIVExtend." Bone Rep 2019.